New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
'Dual-target' cell therapy appears to shrink brain tumors, research finds

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise
Oncology March 20,2024
'Dual-target' cell therapy appears to shrink brain tumors, research finds

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise
Oncology March 20,2024
Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc
Oncology March 20,2024
Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc
Oncology March 20,2024
'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:
Oncology March 20,2024
'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:
Oncology March 20,2024
Researchers gain insight into why T cells lose energy in solid tumors

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca
Oncology March 20,2024
Researchers gain insight into why T cells lose energy in solid tumors

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca
Oncology March 20,2024
Protein discovery sparks treatment hope for aggressive cancer

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein
Oncology March 20,2024
Protein discovery sparks treatment hope for aggressive cancer

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein
Oncology March 20,2024
Age-related changes in skin may contribute to melanoma metastases

Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe
Dermatology March 20,2024
Age-related changes in skin may contribute to melanoma metastases

Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe
Dermatology March 20,2024
Study offers new insights into earliest stages of brain tumor development

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident
Oncology March 20,2024
Study offers new insights into earliest stages of brain tumor development

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident
Oncology March 20,2024
Study finds worsening metabolic syndrome increases the risk of developing cancer

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat
Oncology March 20,2024
Study finds worsening metabolic syndrome increases the risk of developing cancer

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat
Oncology March 20,2024
Financial toxicity found to affect at least one-third of Canadian patients with cancer

Financial toxicity found to affect at least one-third of Canadian patients with cancer

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainAt least one-third of Canadians diagnosed with cancer experience financial distress, called "financial toxicity,&quot
Oncology March 20,2024
Financial toxicity found to affect at least one-third of Canadian patients with cancer

Financial toxicity found to affect at least one-third of Canadian patients with cancer

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainAt least one-third of Canadians diagnosed with cancer experience financial distress, called "financial toxicity,&quot
Oncology March 20,2024
Researchers invent a new class of AI to improve cancer research and treatments

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi
Oncology March 20,2024
Researchers invent a new class of AI to improve cancer research and treatments

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi
Oncology March 20,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com